SEC24A: A Potential Drug Target and Biomarker for Various Diseases

Target Name: SEC24A

NCBI ID: G10802

SEC24A

SEC24A: A Potential Drug Target and Biomarker for Various Diseases

SEC24A (Sec24A), also known as SC24A_HUMAN, is a protein that is expressed in various tissues of the human body. It is a key regulator of the cell cycle, and is essential for the proper functioning of cells.SEC24A has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

SEC24A is a 24-kDa protein that is expressed in the nuclei of human cells. It is a key regulator of the cell cycle, and is involved in the metaphase of the cell cycle, where the chromosomes are replicated and the cell divides.SEC24A plays a crucial role in the regulation of the nuclear envelope, which is the outermost layer of the cell that surrounds the nuclear chromosomes. The nuclear envelope helps to maintain the integrity of the chromosomes and protects them from various forms of damage.

SEC24A is also involved in the regulation of the cytoskeleton, which is the structure that makes up the cell's filaments and fibers. The cytoskeleton helps to maintain the shape and stability of the cell, and is essential for many cellular processes, including cell movement and division.

SEC24A is a protein that has been identified as a potential drug target for various diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of the cell cycle.SEC24A has been shown to play a role in the regulation of the length of the cell cycle, as well as the entry and exit of cells from the cell cycle.

In addition to its role in the cell cycle, SEC24A is also involved in the regulation of cellular signaling pathways. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of many cellular processes, including cell survival, growth, and angiogenesis.

SEC24A is also involved in the regulation of cellular adhesion. It is a key regulator of the cadherin signaling pathway, which is involved in the regulation of cell-cell adhesion and tissue organization.

In addition to its involvement in the regulation of the cell cycle and cellular signaling pathways, SEC24A is also involved in the regulation of cellular processes that are specific to certain cell types. For example, it is involved in the regulation of the cytoskeleton in neural cells, and is thought to play a role in the development and maintenance of the neural network.

Due to its involvement in so many cellular processes, SEC24A has been identified as a potential drug target for various diseases. One of the main targets for SEC24A is cancer, as it is often expressed in the cells of tumors.SEC24A has also been shown to be involved in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, SEC24A has also been identified as a potential biomarker for various diseases. For example, SEC24A has been shown to be involved in the regulation of the lifespan of cancer cells, and is thought to play a role in the development of resistance to chemotherapy.

Overall, SEC24A is a protein that is involved in the regulation of many cellular processes that are essential for the proper functioning of cells. As a potential drug target and biomarker, SEC24A has the potential to be a valuable tool for the development of new treatments for a variety of diseases.

Protein Name: SEC24 Homolog A, COPII Coat Complex Component

Functions: Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:20427317, PubMed:17499046, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24B may have a different specificity compared to SEC24C and SEC24D. May package preferentially cargos with cytoplasmic DxE or LxxLE motifs and may also recognize conformational epitopes (PubMed:17499046, PubMed:18843296)

The "SEC24A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEC24A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets